Research 🇬🇧 Mentions KS

[Video] Targeted Translational Activation Technologies to Treat Haploinsufficiency | Riley Sinnott

person Riley Sinnott, University of Chicago; IDefine

calendar_today Aug 6, 2026

Riley Sinnott of the University of Chicago presents a 2026 Kleefstra Syndrome Scientific Summit talk on developing targeted translational activation technologies, a proposed approach to increase protein production in haploinsufficiency, when one working gene copy does not make enough protein. The page does not provide clinical results.